Effects of Erinacines on Microglial Regulation and Alzheimer's Disease
Author Information
Author(s): Bui Van Thanh, Wu Kuan‐Wei, Chen Chin‐Chu, Nguyen Anh Thuc, Huang Wei‐Jan, Lee Li‐Ya, Chen Wan‐Ping, Huang Chi‐Ying, Shiao Young‐Ji
Primary Institution: National Yang Ming Chiao Tung University
Hypothesis
Can erinacines modulate microglial morphology and alleviate Alzheimer's pathology under metabolic stress?
Conclusion
Erinacines enhance microglial ramification and reduce Alzheimer's disease pathology in a metabolically stressed model.
Supporting Evidence
- Erinacines significantly promoted the development of a ramified, neuroprotective microglial phenotype.
- Erinacines significantly lower fasting blood glucose and insulin levels.
- Erinacines reduced amyloid‐beta plaque burden and enhanced neurogenesis in metabolically stressed APP/PS1 mice.
- Bioinformatics revealed potential modulation of microglia via histone deacetylase inhibition.
- Erinacines improved memory and behavioral deficits in HFSTZ‐APP/PS1 mice.
Takeaway
This study shows that a mushroom extract can help brain cells look and act healthier, which might help treat Alzheimer's disease.
Methodology
The study used rat primary mixed glial cultures and a metabolically stressed APP/PS1 mouse model to evaluate the effects of erinacines.
Limitations
The study primarily used a specific mouse model, which may not fully represent human Alzheimer's disease.
Participant Demographics
APP/PS1 transgenic mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website